Long‐Yun Ye

2.1k total citations
49 papers, 1.5k citations indexed

About

Long‐Yun Ye is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Long‐Yun Ye has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Long‐Yun Ye's work include Pancreatic and Hepatic Oncology Research (10 papers), Immune Cell Function and Interaction (10 papers) and IL-33, ST2, and ILC Pathways (9 papers). Long‐Yun Ye is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Immune Cell Function and Interaction (10 papers) and IL-33, ST2, and ILC Pathways (9 papers). Long‐Yun Ye collaborates with scholars based in China, United States and Hong Kong. Long‐Yun Ye's co-authors include Xianjun Yu, Tingbo Liang, Qida Hu, Xueli Bai, Qi Zhang, Xingyuan Xu, Qi Yang, Qihan Fu, Liang Liu and Wei Chen and has published in prestigious journals such as Nature Immunology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Long‐Yun Ye

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Long‐Yun Ye China	22	613	549	490	384	255	49	1.5k
Yan‐Miao Huo China	21	276 0.5×	559 1.0×	534 1.1×	435 1.1×	150 0.6×	54	1.2k
Xing-Juan Yu China	20	706 1.2×	442 0.8×	559 1.1×	301 0.8×	76 0.3×	29	1.3k
Jérémy Bastid France	15	480 0.8×	697 1.3×	888 1.8×	295 0.8×	76 0.3×	22	1.6k
Defeng Deng United States	18	280 0.5×	703 1.3×	476 1.0×	362 0.9×	218 0.9×	29	1.3k
Chongbiao Huang China	26	439 0.7×	824 1.5×	765 1.6×	598 1.6×	125 0.5×	49	1.7k
Aiqin Gao China	16	669 1.1×	391 0.7×	577 1.2×	289 0.8×	68 0.3×	38	1.3k
M. Reza Saadatzadeh United States	17	172 0.3×	956 1.7×	328 0.7×	297 0.8×	302 1.2×	38	1.6k
Richard A. Baylis United States	13	562 0.9×	464 0.8×	185 0.4×	118 0.3×	165 0.6×	22	1.0k
Juling Ji China	14	334 0.5×	646 1.2×	225 0.5×	384 1.0×	92 0.4×	36	1.3k
David A. Leinster United Kingdom	6	485 0.8×	383 0.7×	486 1.0×	246 0.6×	74 0.3×	7	1.1k

Countries citing papers authored by Long‐Yun Ye

Since Specialization

Citations

This map shows the geographic impact of Long‐Yun Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long‐Yun Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long‐Yun Ye more than expected).

Fields of papers citing papers by Long‐Yun Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long‐Yun Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long‐Yun Ye. The network helps show where Long‐Yun Ye may publish in the future.

Co-authorship network of co-authors of Long‐Yun Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Long‐Yun Ye. A scholar is included among the top collaborators of Long‐Yun Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long‐Yun Ye. Long‐Yun Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Huiru, Tianjiao Li, Xianjun Yu, et al.. (2024). The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell Death and Disease. 15(4). 244–244. 14 indexed citations

Ye, Long‐Yun, et al.. (2024). The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer. Computational and Structural Biotechnology Journal. 23. 3634–3650. 3 indexed citations

Ye, Long‐Yun, et al.. (2023). Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. Cell Death and Disease. 14(11). 778–778. 7 indexed citations

Ye, Long‐Yun, et al.. (2023). Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. Acta Biochimica et Biophysica Sinica. 55(6). 923–937. 4 indexed citations

Gao, Heli, Wuhu Zhang, Huaxiang Xu, et al.. (2022). The optimal duration of capecitabine plus temozolomide in patients with well‐differentiated pancreatic NETs with or without maintenance therapy. Journal of Neuroendocrinology. 34(6). e13112–e13112. 1 indexed citations

Zhang, Huiru, Long‐Yun Ye, Xianjun Yu, Kaizhou Jin, & Weiding Wu. (2022). Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer. Frontiers in Immunology. 13. 956984–956984. 23 indexed citations

Zhou, Zhiyang, Jin Li, Jian Shen, et al.. (2022). COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer. Acta Biochimica et Biophysica Sinica. 55(1). 34–42. 3 indexed citations

Ye, Long‐Yun, Kaizhou Jin, Zhiwen Xiao, et al.. (2022). Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer. EBioMedicine. 79. 104016–104016. 18 indexed citations

Sun, Jing, Xiaoxiao Zheng, Ying Cai, et al.. (2021). LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells. Acta Biochimica et Biophysica Sinica. 54(2). 261–270. 21 indexed citations

10.

Gao, Heli, Wuhu Zhang, Huaxiang Xu, et al.. (2021). Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors. Endocrine Practice. 28(3). 292–297. 2 indexed citations

11.

Wang, Yi, Haitao Yu, Xiaozai Xie, et al.. (2021). Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway. Oncogene. 40(25). 4324–4337. 26 indexed citations

12.

Wang, Jiang, et al.. (2020). Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188392–188392. 66 indexed citations

13.

Zhang, Wuhu, Wenquan Wang, Xuan Han, et al.. (2020). Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective. Computational and Structural Biotechnology Journal. 18. 3606–3614. 22 indexed citations

14.

Guo, Pengyi, Yi Wang, Fang Wu, et al.. (2017). Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma. Oncogene. 37(9). 1220–1236. 54 indexed citations

15.

Ye, Long‐Yun, Wei Chen, Xueli Bai, et al.. (2016). Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis. Cancer Research. 76(4). 818–830. 233 indexed citations

16.

Yang, Qi, Fengyin Li, Christelle Harly, et al.. (2015). TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nature Immunology. 16(10). 1044–1050. 215 indexed citations

17.

Bai, Xueli, Qi Zhang, Long‐Yun Ye, et al.. (2014). Inhibition of Protein Phosphatase 2A Enhances Cytotoxicity and Accessibility of Chemotherapeutic Drugs to Hepatocellular Carcinomas. Molecular Cancer Therapeutics. 13(8). 2062–2072. 31 indexed citations

18.

Bai, Xueli, Long‐Yun Ye, Qi Zhang, et al.. (2014). Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution. World Journal of Surgical Oncology. 12(1). 228–228. 11 indexed citations

19.

Liu, Daren, Bogusz Trojanowicz, Long‐Yun Ye, et al.. (2012). The Invasion and Metastasis Promotion Role of CD97 Small Isoform in Gastric Carcinoma. PLoS ONE. 7(6). e39989–e39989. 35 indexed citations

20.

Ye, Long‐Yun, Jingjing Wang, Daren Liu, Guoping Ding, & Liping Cao. (2012). Management of giant ovarian teratoma: A case series and review of the literature. Oncology Letters. 4(4). 672–676. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact